{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:31:53Z","timestamp":1781883113381,"version":"3.54.5"},"reference-count":91,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Health, Labor and Welfare, Government of Japan"},{"name":"Ministry of Science and Technology, Government of India"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.vaccine.2011.08.059","type":"journal-article","created":{"date-parts":[[2011,9,7]],"date-time":"2011-09-07T10:35:32Z","timestamp":1315391732000},"page":"8205-8214","source":"Crossref","is-referenced-by-count":40,"title":["Mucosal immunity and poliovirus vaccines: Impact on wild poliovirus infection and transmission"],"prefix":"10.1016","volume":"29","author":[{"given":"Hiromasa","family":"Okayasu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland W.","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecil","family":"Czerkinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pearay L.","family":"Ogra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.08.059_bib0005","unstructured":"Global Polio Eradication Initiative. Annual Report 2009. Available from: http:\/\/www.polioeradication.org\/content\/publications\/AnnualReport2009_ENGChap2.pdf [accessed 06.06.11]."},{"key":"10.1016\/j.vaccine.2011.08.059_bib0010","unstructured":"Global Polio Eradication Initiative. Polio this week. Available from: http:\/\/www.polioeradication.org\/casecount.asp [accessed 07.07.11]."},{"key":"10.1016\/j.vaccine.2011.08.059_bib0015","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0031-3955(16)36908-5","article-title":"Poliovirus vaccines. A continuing challenge","volume":"37","author":"Kimpen","year":"1990","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0020","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1128\/JVI.76.11.5339-5349.2002","article-title":"Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains","volume":"76","author":"Mart\u00edn","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0025","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1099\/0022-1317-67-7-1283","article-title":"Antigenic structure of polioviruses of serotypes 1, 2 and 3","volume":"67","author":"Minor","year":"1986","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0030","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1086\/342682","article-title":"Immunofluorescence analysis of poliovirus receptor expression in Peyer's patches of humans, primates, and CD155 transgenic mice: implications for poliovirus infection","volume":"186","author":"Iwasaki","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0035","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0031-3955(16)36908-5","article-title":"Poliovirus vaccines: a continuing challenge","volume":"37","author":"Kimpen","year":"1990","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0040","unstructured":"World Health Organization. WHO Vaccine-preventable diseases: monitoring system \u2013 2009 global summary, Available from: http:\/\/www.who.int\/immunization\/documents\/WHO_IVB_2009\/en\/index.html; 2009 December [accessed 06.06.11]."},{"key":"10.1016\/j.vaccine.2011.08.059_bib0045","unstructured":"Global poliovirus eradication initiative. Independent evaluation of major barriers to interrupting poliovirus transmission in India, Available from: http:\/\/www.polioeradication.org\/content\/publications\/AnnualReport2009_ENG.pdf; 2009 October [accessed 06.06.11]."},{"key":"10.1016\/j.vaccine.2011.08.059_bib0050","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1086\/651952","article-title":"Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccination","volume":"201","author":"Grassly","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0055","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0060","first-page":"495","article-title":"Oral poliovirus vaccine in tropical Africa; greater impact on incidence of paralytic disease than expected from coverage surveys and seroconversion rates","volume":"65","author":"Heyman","year":"1987","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0065","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0140-6736(91)91442-W","article-title":"Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among vaccinated children","volume":"338","author":"Sutter","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0070","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1126\/science.1130388","article-title":"New strategies for the elimination of polio from India","volume":"314","author":"Grassly","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0075","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/clinids\/13.5.926","article-title":"Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries","volume":"13","author":"Patriarca","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0080","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(10)61230-5","article-title":"Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial","volume":"376","author":"Sutter","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0085","series-title":"Vaccines","first-page":"605","article-title":"Poliovirus vaccine \u2013 inactivated","author":"Plotkin","year":"2008"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0090","series-title":"Measles and poliomyelitis \u2013 vaccines and immunization","first-page":"279","article-title":"Inactivated and live, attenuated poliovirus vaccines: mucosal immunity","author":"Sutter","year":"1993"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0095","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/infdis\/158.1.160","article-title":"Characteristics of the immune response to poliovirus virion peptides after immunization with live or inactivated polio vaccines","volume":"158","author":"Zhaori","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0100","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/infdis\/162.6.1291","article-title":"Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses","volume":"162","author":"Faden","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/163.1.1","article-title":"Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines","volume":"163","author":"Onorato","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0110","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMoa0800390","article-title":"Monovalent type 1 oral poliovirus vaccine in newborns","volume":"359","author":"el-Sayed","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0115","unstructured":"World Health Organization. Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. Weekly Epidemiological Record 2010; No. 23, p. 213\u201328. Available from: http:\/\/www.who.int\/wer\/2010\/wer8523\/en\/index.html; 2010 June [accessed 06.06.11]."},{"key":"10.1016\/j.vaccine.2011.08.059_bib0120","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1056\/NEJMoa0803259","article-title":"Effectiveness of immunization against paralytic poliomyelitis in Nigeria","volume":"359","author":"Jenkins","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0125","series-title":"Report of the interim meeting of the Technical Consultative Group (TCG) on the Global Eradication of Poliomyelitis","article-title":"Risk assessment: frequency and burden of VAPP, cVDPV and iVDPV","author":"World Health Organization","year":"2002"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0130","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0135","unstructured":"Global Polio Eradication Initiative. Circulating vaccine-derived poliovirus1 (cVDPV) 2000\u20132011. Available from: http:\/\/www.polioeradication.org\/Dataandmonitoring\/Poliothisweek\/Circulatingvaccinederivedpoliovirus.aspx [accessed 06.06.11]."},{"key":"10.1016\/j.vaccine.2011.08.059_bib0140","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0140-6736(88)91711-4","article-title":"Clinical efficacy of a new, enhanced-potency, inactivated poliovirus vaccine","volume":"1","author":"Robertson","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0145","series-title":"World Conference on Poliomyelitis and Measles","article-title":"Poliovirus vaccine and poliomyelitis control in India [abstract]","author":"John","year":"1992"},{"key":"10.1016\/j.vaccine.2011.08.059_bib30","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.292.14.1696","article-title":"Vaccine policy changes and epidemiology of poliomyelitis in the United States","volume":"292","author":"Alexander","year":"2004","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.vaccine.2011.08.059_bib0155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1086\/508427","article-title":"Serologic response to inactivated poliovirus vaccine; a randomized clinical trial comparing 2 vaccination schedules in Puerto Rico","volume":"195","author":"Dayan","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0160","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1056\/NEJMoa054960","article-title":"Randomized, placebo-controlled trial of inactivated poliovirus in Cuba","volume":"356","author":"Cuba IPV Study Collaborative Group","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0165","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0031-3955(16)36908-5","article-title":"Poliovirus vaccines. A continuing challenge","volume":"37","author":"Kimpen","year":"1990","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0170","doi-asserted-by":"crossref","first-page":"S471","DOI":"10.1093\/clinids\/6.Supplement_2.S471","article-title":"Vaccination with inactivated poliovirus vaccine and oral poliovirus vaccine in Denmark","volume":"6","author":"Von Magnus","year":"1984","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0175","doi-asserted-by":"crossref","first-page":"S413","DOI":"10.1093\/clinids\/6.Supplement_2.S413","article-title":"Experiences associated with the use of live poliovirus vaccine in Hungary, 1959\u20131982","volume":"6","author":"D\u00f6m\u00f6k","year":"1984","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0180","first-page":"137","article-title":"Combined live and inactivated poliovirus vaccine to control poliomyelitis in a developing country \u2013 five years after","volume":"65","author":"Lasch","year":"1986","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0185","first-page":"253","article-title":"Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand","volume":"74","author":"WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines","year":"1996","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0190","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0264-410X(02)00523-6","article-title":"Serological response and poliovirus excretion following different combined oral and inactivated poliovirus vaccines immunization schedules","volume":"21","author":"du Chatelet","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0195","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1093\/infdis\/175.Supplement_1.S228","article-title":"Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules","volume":"175","author":"Modlin","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0200","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.4049\/jimmunol.162.8.5011","article-title":"Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus","volume":"162","author":"Herremans","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0205","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/S0264-410X(00)00515-6","article-title":"Inactivated poliovirus vaccine and the final stages of poliovirus eradication","volume":"19","author":"Hovi","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0210","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1056\/NEJMoa054960","article-title":"Randomized, placebo-controlled trial of inactivated poliovirus in Cuba","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0215","first-page":"265","article-title":"Comparison of the resistance of the intestinal tract to poliomyelitis virus (Sabin's strains) in person after naturally and experimentally acquired immunity","volume":"5","author":"Ghendon","year":"1961","journal-title":"Acta Virologica (Praha)"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0220","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1017\/S0022172400040389","article-title":"A study of polio vaccination in infancy: excretion following challenge with live virus by children given killed or living poliovaccine","volume":"64","author":"Henry","year":"1966","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/163.1.1","article-title":"Mucosal immunity induced by enhanced potency IPV and OPV","volume":"163","author":"Onorato","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0230","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1093\/infdis\/175.Supplement_1.S228","article-title":"Humoral and mucosal immunity in infants induced by three sequential IPV\u2013OPV immunization schedules","volume":"75","author":"Modlin","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0235","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1126\/science.1183021","article-title":"Regulation of adaptive immunity by the innate immune system","volume":"327","author":"Iwasaki","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0240","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nri2075","article-title":"Innate immunity of the newborn: basic mechanisms and clinical correlates","volume":"7","author":"Levy","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0245","doi-asserted-by":"crossref","unstructured":"Wilson CB, Kollmann TR. Induction of antigen-specific immunity in human neonates and infants. Nestle Nutr Workshop Ser Pediatr Program 2008;61:183\u201395.","DOI":"10.1159\/000113493"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0250","series-title":"Presented at: Euroconference: Nutrition, Immune Functions and Health","article-title":"Mucosal adaptive immunity: impact of exogenous stimuli and feeding","author":"Brandtzaeg","year":"2005"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0255","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1651-2227.1994.tb13219.x","article-title":"Ontogeny of gut associated lymphoid system in man","volume":"83","author":"MacDonald","year":"1994","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0260","doi-asserted-by":"crossref","unstructured":"Ogra PL, Welliver RC Sr. Effects of early environment on mucosal immunologic homeostasis, subsequent immune responses, and disease outcome. In: Barker DJP, Bergmann RL, Ogra PL, editors. The window of opportunity: pre-pregnancy to 24 months of Age. Nestle Nutrition Workshop Ser Pediatr Program, vol. 6. Nestec Ltd, Vevey\/S Karger AG, Basel, Switzerland; 2008. p. 145\u201381.","DOI":"10.1159\/000113492"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0265","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/tropej\/43.4.232","article-title":"Systemic and mucosal immune response to polio vaccination with additional dose in newborn period","volume":"43","author":"Bhaskaram","year":"1997","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0270","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0022-3476(05)80228-8","article-title":"Systemic and local immune responses to enhanced-potency inactivated poliovirus vaccine in premature and term infants","volume":"120","author":"Adenyi-Jones","year":"1992","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0275","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1086\/649590","article-title":"Preterm infants\u2019 T cell responses to inactivated poliovirus vaccine","volume":"201","author":"Klein","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0280","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2249.2002.01788.x","article-title":"T cell responses to vaccines in infants: defective IFNgamma production after oral polio vaccination","volume":"127","author":"Vekemans","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0285","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1084\/jem.181.4.1285","article-title":"Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor","volume":"181","author":"Mahon","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0290","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0264-410X(90)90244-G","article-title":"Polio immunity to killed vaccine: an 18-year follow up","volume":"8","author":"B\u00f6ttiger","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0295","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1099\/vir.0.79919-0","article-title":"Gut-homing (alpha(4)beta(7)(+)) Th1 memory responses after inactivated poliovirus immunization in poliovirus orally pre-immunized donors","volume":"85","author":"Krieg","year":"2004","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0300","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.smim.2004.02.008","article-title":"Immunological memory in humans","volume":"16","author":"Crotty","year":"2004","journal-title":"Semin Immunol"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0305","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/346749a0","article-title":"Maintenance of B-cell memory by long-lived cells generated from proliferating precursors","volume":"346","author":"Schittek","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0310","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/ni0910-769","article-title":"Improving the performance of enteric vaccines in the developing world","volume":"11","author":"Serazin","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0315","doi-asserted-by":"crossref","first-page":"464S","DOI":"10.1093\/ajcn\/66.2.464S","article-title":"Synergism of nutrition, infection, and immunity: an overview","volume":"66","author":"Scrimshaw","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0320","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/08820138909112233","article-title":"Effect of nutritional deprivation on mucosal viral infections","volume":"18","author":"Riepenhoff-Talty","year":"1989","journal-title":"Immunol Invest"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0325","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/tropej\/40.6.345","article-title":"Evaluation of immune response in infants with different nutritional status: vaccinated against tuberculosis, measles and poliomyelitis","volume":"40","author":"Adeiga","year":"1994","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0330","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1093\/jn\/132.11.3243","article-title":"Vitamin A supplementation of women postpartum and of their infants at immunization alters breast milk retinol and infant vitamin A status","volume":"132","author":"Bahl","year":"2002","journal-title":"J Nutr"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0335","doi-asserted-by":"crossref","first-page":"474","DOI":"10.26719\/2004.10.4-5.474","article-title":"Evaluation of the response to vaccination against poliomyelitis and measles in malnourished children in Morocco","volume":"10","author":"Caidi","year":"2004","journal-title":"East Mediterr Health J"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0340","series-title":"Live Poliovirus Vaccines: Papers Presented and Discussions Held at the First International Conference on Live Poliovirus Vaccines. Special Publication No. 44","article-title":"Poliomyelitis infection rate among Mexican children fed attenuated poliovirus vaccines","author":"Benyesh-Melnick","year":"1959"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0345","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00006454-199603000-00006","article-title":"Effect of diarrhea on the humoral response to oral polio vaccination","volume":"15","author":"Myaux","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0350","first-page":"1320","article-title":"Effect of concurrent viral infection on systemic and local antibody responses to live attenuated and enhanced-potency inactivated poliovirus vaccines","volume":"146","author":"Faden","year":"1992","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0355","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/oxfordjournals.aje.a121457","article-title":"Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference","volume":"96","author":"John","year":"1972","journal-title":"Am. J. Epidemiol"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0360","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0140-6736(09)60950-8","article-title":"Child undernutrition, tropical enteropathy, toilets, and handwashing","volume":"374","author":"Humphrey","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0365","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1203\/01.PDR.0000141955.47550.A0","article-title":"Increased poliovirus-specific intestinal antibody response coincides with promotion of Bifidobacterium longum-infantis and Bifidobacterium breve in infants: a randomized, double-blind, placebo-controlled trial","volume":"56","author":"Mulli\u00e9","year":"2004","journal-title":"Pediatr Res"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0370","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3168\/jds.S0022-0302(91)78272-6","article-title":"Enhancement of immune response in Peyer's patch cells cultured with Bifidobacterium breve","volume":"74","author":"Yasui","year":"1991","journal-title":"J Dairy Sci"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0375","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2217\/phe.10.67","article-title":"Mucosal immune system in neonatal period and early infancy","volume":"179","author":"Ogra","year":"2010","journal-title":"Pediatric Health"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0380","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.4049\/jimmunol.179.9.5633","article-title":"Perspectives on mucosal vaccines: is mucosal tolerance a barrier?","volume":"179","author":"Mestecky","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0385","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJM196105252642102","article-title":"Effect of Sabin type 1 poliomyelitis vaccine administered by mouth to newborn infants","volume":"264","author":"Lepow","year":"1961","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0390","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1056\/NEJMoa054960","article-title":"Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0395","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1086\/508427","article-title":"Serologic response to inactivated poliovirus vaccine: a randomized clinical trial comparing 2 vaccination schedules in Puerto Rico","volume":"195","author":"Dayan","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0400","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0022-3476(68)80084-8","article-title":"Oral polio immunization of the newborn infant: a possible method for overcoming interference by ingested antibodies","volume":"73","author":"Katz","year":"1968","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0405","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.vaccine.2008.12.036","article-title":"Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding","volume":"27","author":"Ahmed","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0410","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1542\/peds.57.1.47","article-title":"Effect of breast-feeding on seroresponse of infants to oral poliovirus vaccination","volume":"57","author":"John","year":"1976","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0415","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1016\/j.vaccine.2011.04.133","article-title":"Monovalent type 1 oral poliovirus vaccine among infants in India: Report of two randomized double-blind controlled clinical trials","volume":"29","author":"John","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0420","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1542\/peds.101.2.242","article-title":"Modulation of the immune system by human milk and infant formula containing nucleotides","volume":"101","author":"Pickering","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0425","doi-asserted-by":"crossref","first-page":"e10328","DOI":"10.1371\/journal.pone.0010328","article-title":"Oral polio vaccine influences the immune response to BCG vaccination. A natural experiment","volume":"5","author":"Sartono","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0430","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4049\/jimmunol.168.2.919","article-title":"Influence of Mycobacterium bovis bacillus Calmette-Gu\u00e9rin on antibody and cytokine responses to human neonatal vaccination","volume":"168","author":"Ota","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0435","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1093\/infdis\/174.Supplement_1.S107","article-title":"Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines","volume":"174","author":"Rennels","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0440","first-page":"1093","article-title":"Contamination of drinking-water by arsenic in Bangladesh: a public health emergency","volume":"78","author":"Smith","year":"2000","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0445","unstructured":"Global poliovirus eradication initiative. Independent evaluation of major barriers to interrupting poliovirus transmission in India, Available from: http:\/\/www.polioeradication.org\/content\/general\/Polio_Evaluation_IND.pdf; 2009 October [accessed 06.06.11]"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0450","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1586\/erv.09.61","article-title":"Mucosal vaccines: novel advances in technology and delivery","volume":"8","author":"Yuki","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2011.08.059_bib0455","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1016\/j.vaccine.2010.02.010","article-title":"Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization","volume":"28","author":"Tonkin","year":"2010","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11013053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11013053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T01:26:42Z","timestamp":1712798802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11013053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":91,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0264410X11013053"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.08.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}